Cormorant Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Cormorant Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-200,000	Closed	-$9.17M	–	80
2017 Q1	$9.17M	Hold	200,000	–	–	1.33%	28
2016 Q4	$10.5M	Hold	200,000	–	–	1.42%	22
2016 Q3	$8.92M	Hold	200,000	–	–	0.98%	31
2016 Q2	$7.63M	Buy	+200,000	New	+$8.79M	1.08%	34

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cormorant Asset Management's SYNH Position: Q2 2017 in Review

Cormorant Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2017, closing a stake of 200,000 shares — an estimated $9.17M sold.

Cormorant Asset Management first reported a position in SYNH in Q2 2016 and held it in 4 quarters. The position peaked at $10.5M in Q4 2016. 247 funds tracked by Wall St. Rank hold SYNH as of Q2 2017.

Cormorant Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2017 after selling out during the quarter.
Cormorant Asset Management sold 200,000 Syneos Health, Inc. Class A Common Stock shares in Q2 2017, an estimated $9.17M.
Cormorant Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and held it in 4 quarters.
Cormorant Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $10.5M in Q4 2016.
247 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2017.

Based on Cormorant Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.